IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()

The mainstay treatment of Clostridium difficile infections (CDI) is antimicrobials with growing support for fecal microbiota transplants. We report the first case of an elderly man with severe refractory NAP-1 pseudomembranous CDI who failed all medical therapy and two fecal transplants with respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Coffman, Kelley, Chen, Xian Jie Cindy, Okamura, Charles, Louie, Eddie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348590/
https://www.ncbi.nlm.nih.gov/pubmed/28331803
http://dx.doi.org/10.1016/j.idcr.2017.03.002
_version_ 1782514264378966016
author Coffman, Kelley
Chen, Xian Jie Cindy
Okamura, Charles
Louie, Eddie
author_facet Coffman, Kelley
Chen, Xian Jie Cindy
Okamura, Charles
Louie, Eddie
author_sort Coffman, Kelley
collection PubMed
description The mainstay treatment of Clostridium difficile infections (CDI) is antimicrobials with growing support for fecal microbiota transplants. We report the first case of an elderly man with severe refractory NAP-1 pseudomembranous CDI who failed all medical therapy and two fecal transplants with response only seen after administration of intravenous immunoglobulin.
format Online
Article
Text
id pubmed-5348590
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53485902017-03-22 IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin() Coffman, Kelley Chen, Xian Jie Cindy Okamura, Charles Louie, Eddie IDCases Case Report The mainstay treatment of Clostridium difficile infections (CDI) is antimicrobials with growing support for fecal microbiota transplants. We report the first case of an elderly man with severe refractory NAP-1 pseudomembranous CDI who failed all medical therapy and two fecal transplants with response only seen after administration of intravenous immunoglobulin. Elsevier 2017-03-06 /pmc/articles/PMC5348590/ /pubmed/28331803 http://dx.doi.org/10.1016/j.idcr.2017.03.002 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Coffman, Kelley
Chen, Xian Jie Cindy
Okamura, Charles
Louie, Eddie
IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()
title IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()
title_full IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()
title_fullStr IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()
title_full_unstemmed IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()
title_short IVIG – A cure to severe refractory NAP-1 Clostridium difficile colitis? A case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()
title_sort ivig – a cure to severe refractory nap-1 clostridium difficile colitis? a case of successful treatment of severe infection, which failed standard therapy including fecal microbiota transplants and fidaxomicin()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348590/
https://www.ncbi.nlm.nih.gov/pubmed/28331803
http://dx.doi.org/10.1016/j.idcr.2017.03.002
work_keys_str_mv AT coffmankelley ivigacuretosevererefractorynap1clostridiumdifficilecolitisacaseofsuccessfultreatmentofsevereinfectionwhichfailedstandardtherapyincludingfecalmicrobiotatransplantsandfidaxomicin
AT chenxianjiecindy ivigacuretosevererefractorynap1clostridiumdifficilecolitisacaseofsuccessfultreatmentofsevereinfectionwhichfailedstandardtherapyincludingfecalmicrobiotatransplantsandfidaxomicin
AT okamuracharles ivigacuretosevererefractorynap1clostridiumdifficilecolitisacaseofsuccessfultreatmentofsevereinfectionwhichfailedstandardtherapyincludingfecalmicrobiotatransplantsandfidaxomicin
AT louieeddie ivigacuretosevererefractorynap1clostridiumdifficilecolitisacaseofsuccessfultreatmentofsevereinfectionwhichfailedstandardtherapyincludingfecalmicrobiotatransplantsandfidaxomicin

Ejemplares similares